These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 18020899)

  • 1. Genomic tests: unreliable for cancer? A focus on circulating DNA and lung cancer.
    Teare MD; Woll PJ
    Expert Rev Mol Diagn; 2007 Nov; 7(6):699-702. PubMed ID: 18020899
    [No Abstract]   [Full Text] [Related]  

  • 2. Free circulating nucleic acids in plasma and serum (CNAPS) -- Useful for the detection of lung cancer patients?
    Fleischhacker M; Schmidt B
    Cancer Biomark; 2010; 6(3-4):211-9. PubMed ID: 20660966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating DNA and lung cancer.
    Xue X; Zhu YM; Woll PJ
    Ann N Y Acad Sci; 2006 Sep; 1075():154-64. PubMed ID: 17108206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic potential of circulating nucleic acids for oncology.
    Goessl C
    Expert Rev Mol Diagn; 2003 Jul; 3(4):431-42. PubMed ID: 12877383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early detection of lung cancer using serum RNA or DNA markers: ready for "prime time" or for validation?
    Bunn PJ
    J Clin Oncol; 2003 Nov; 21(21):3891-3. PubMed ID: 14507944
    [No Abstract]   [Full Text] [Related]  

  • 6. [Advances in research on circulating nucleic acids as diagnostic markers for cancer].
    Jing RR; Wang HM; Wang ZW
    Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):881-4. PubMed ID: 22340094
    [No Abstract]   [Full Text] [Related]  

  • 7. Reproducibility of a semiquantitative measurement of circulating DNA in plasma from neoplastic patients.
    Frattini M; Balestra D; Verderio P; Gallino G; Leo E; Sozzi G; Pierotti MA; Daidone MG
    J Clin Oncol; 2005 May; 23(13):3163-4; author reply 3164-5. PubMed ID: 15860889
    [No Abstract]   [Full Text] [Related]  

  • 8. Circulating tumour-derived nucleic acids in cancer patients: potential applications as tumour markers.
    Chan KC; Lo YM
    Br J Cancer; 2007 Mar; 96(5):681-5. PubMed ID: 17311021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer.
    Paci M; Maramotti S; Bellesia E; Formisano D; Albertazzi L; Ricchetti T; Ferrari G; Annessi V; Lasagni D; Carbonelli C; De Franco S; Brini M; Sgarbi G; Lodi R
    Lung Cancer; 2009 Apr; 64(1):92-7. PubMed ID: 18804892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating nucleic acids in plasma/serum.
    Tsang JC; Lo YM
    Pathology; 2007 Apr; 39(2):197-207. PubMed ID: 17454749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating nucleic acids in cancer and pregnancy.
    Pinzani P; Salvianti F; Pazzagli M; Orlando C
    Methods; 2010 Apr; 50(4):302-7. PubMed ID: 20146940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-free nucleic acids in plasma, serum and urine: a new tool in molecular diagnosis.
    Chan AK; Chiu RW; Lo YM;
    Ann Clin Biochem; 2003 Mar; 40(Pt 2):122-30. PubMed ID: 12662399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating tumour-derived predictive biomarkers in oncology.
    Hodgson DR; Wellings R; Orr MC; McCormack R; Malone M; Board RE; Cantarini MV
    Drug Discov Today; 2010 Feb; 15(3-4):98-101. PubMed ID: 20045486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Application status of circulating nucleic acids as biomarkers in gastric cancer].
    Li L; Zhang L; Ji J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Jan; 17(1):21-5. PubMed ID: 24519044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood, spit, and breath: scientists search for noninvasive tests for lung cancer.
    Beckman M
    J Natl Cancer Inst; 2007 Feb; 99(3):191. PubMed ID: 17284711
    [No Abstract]   [Full Text] [Related]  

  • 16. [Tumor markers in lung cancer].
    Gómez de Terreros Caro FJ; Alvarez-Sala Walther R; Prados Sánchez C; Díaz Ajero P
    An Med Interna; 2001 May; 18(5):289. PubMed ID: 11496575
    [No Abstract]   [Full Text] [Related]  

  • 17. Integrity of cell-free plasma DNA in patients with lung cancer and nonmalignant lung disease.
    Schmidt B; Weickmann S; Witt C; Fleischhacker M
    Ann N Y Acad Sci; 2008 Aug; 1137():207-13. PubMed ID: 18837948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for circulating nucleic acids and caspase activity in the peripheral blood as potential diagnostic tools in lung cancer.
    Roth C; Kasimir-Bauer S; Pantel K; Schwarzenbach H
    Mol Oncol; 2011 Jun; 5(3):281-91. PubMed ID: 21398193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum tumor markers in lung cancer].
    Dediu M
    Pneumologia; 1999; 48(4):321-2. PubMed ID: 10856996
    [No Abstract]   [Full Text] [Related]  

  • 20. Current challenges in lung cancer early detection biomarkers.
    Montuenga LM; Pio R
    Eur J Cancer; 2009 Sep; 45 Suppl 1():377-8. PubMed ID: 19775637
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.